BioCentury
ARTICLE | Clinical News

Tribenzor olmesartan/amlodipine/hydrochlorothiazide regulatory update

August 2, 2010 7:00 AM UTC

Daiichi Sankyo Co. Ltd. (Tokyo:4568; Osaka:4568), Tokyo, Japan Product: Tribenzor olmesartan/amlodipine/hydrochlorothiazide ( CS-8635) Business: Cardiovascular FDA approved an NDA from Daiichi for Tr...